Muscle Invasive Bladder CancerSymptoms, Doctors, Treatments, Advances & More
Learn About Muscle Invasive Bladder Cancer
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Cleveland Clinic Main Campus
Christopher Weight is a General Surgeon practicing medicine in Cleveland, Ohio. Dr. Weight is rated as an Elite provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Muscle Invasive Bladder Cancer, Non-Muscle Invasive Bladder Cancer, Upper Tract Urothelial Carcinoma (UTUC), Nephrectomy, and Cystectomy. Dr. Weight is currently accepting new patients.
Prostate Cancer Center
Sima Porten is an Oncologist practicing medicine in San Francisco, California. Dr. Porten is rated as an Elite provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. She is also highly rated in 11 other conditions, according to our data. Her clinical expertise encompasses Bladder Cancer, Urothelial Cancer, Muscle Invasive Bladder Cancer, Nephrectomy, and Reconstructive Urology Surgery. Dr. Porten is board certified in American Board Of Urology, Urology. Dr. Porten is currently accepting new patients.
UT MD Anderson Cancer Center
Ashish Kamat is a Urologist practicing medicine in Cary, North Carolina. Dr. Kamat is rated as an Elite provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. He is also highly rated in 15 other conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Non-Muscle Invasive Bladder Cancer, Muscle Invasive Bladder Cancer, Cystectomy, and Lymphadenectomy.
Summary: This phase II trial tests the effect of giving pembrolizumab in combination with radiation therapy after chemotherapy in preventing surgery to remove the bladder in patients with muscle invasive bladder cancer. Standard of care therapy includes chemotherapy before surgery (neoadjuvant) to shrink or get rid of the tumor. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the ...
Summary: This pilot feasibility clinical trial is evaluating a novel treatment strategy for patients with advanced bladder cancer that is unresectable, has spread to nearby lymph nodes or a limited number of distant sites (oligometastatic disease), and has responded to initial treatment with enfortumab vedotin and pembrolizumab. Although this combination has significantly improved outcomes compared to trad...